id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-P-0083-0001,FDA,FDA-1998-P-0083,Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for Hearing,Notice,NPH-Notice of Opportunity of Hearing,2003-04-16T04:00:00Z,2003,4,,,2012-09-22T18:15:24Z,,0,0,0900006480584b32
FDA-1998-P-0083-0002,FDA,FDA-1998-P-0083,Reference List Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for Hearing - Background Material re FDA-1998-P-0083-0001,Supporting & Related Material,Background Material,2003-04-16T04:00:00Z,2003,4,,,2012-09-22T18:34:22Z,,0,0,0900006480584bfa